Lingshan Iron and Steel Co., Ltd.'s reform of equity diversification and acceleration of Fangda held up the license twice in half a year.-Shanghai Metals Market

Hot Keywords

  • Silicon
  • Inventory data
  • Nickel
  • Aluminium
  • 铜管/铜管
  • Copper scrap
  • Rare earth
  • MMi Iron Ore Port Index
  • Macroeconomics
  • Market commentary
  • Copper
  • Zinc
  • provisional iron ore export permits
  • Evening comments
  • Futures movement

Lingshan Iron and Steel Co., Ltd.'s reform of equity diversification and acceleration of Fangda held up the license twice in half a year.

Translation 08:26:26AM Jun 12, 2019 Source:Securities Daily
The content below was translated by Tencent automatically for reference.

SMM network news: Fang Dajie once again to Liaoning state-owned enterprises. On the evening of June 10, Linggang announced that during the period from March 8, 2019 to June 10, 2019, Jiujiang Pinggang, owned by Fang Dajie, increased its stake in the company by way of centralized bidding. Fangwei increased its stake by 120000 shares, and the two increased their holdings by 138.5541 million shares, accounting for 5.00 per cent of the total share capital of the company. This is also the second time that Fang Da has raised its license since it was transferred by agreement to transfer 173 million shares of Linggang shares in February this year. So far, Jiujiang Pinggang and its unanimous actor Fang Wei have a total of 319 million shares in Linggang, accounting for 11.50 per cent of the total share capital of the company.

The reporter learned that Linggang Group, as the controlling shareholder of Linggang shares, is also a focus of the reform of state-owned enterprises in recent years. In August last year, the State-owned assets Supervision and Administration Commission of the State Council released a list of "two hundred actions" for the reform of state-owned enterprises, among which Linggang Group was among them.

Linggang Group, founded in 1966, is the largest municipal state-owned enterprise in Chaoyang City, Liaoning Province, with a steel production capacity of 6 million tons. Linggang shares, which were listed on the Shanghai Stock Exchange in 2000, are the most important operating body of Linggang Group at present. At the end of February 2019, the ownership structure of Linggang changed greatly. Fang Dajie and Rongcheng Group accepted the shares originally held by Guangfa Fund and Huafu Fund by way of agreement transfer, both of which became important shareholders of Linggang shares.

In just a few months, Fang Dazhi's increase in his stake in Linggang is also reminiscent of a series of operations on Northeast China Pharmaceutical last year. In 2018, after becoming an important shareholder of Northeast Pharmaceutical through the issuance of additional shares, Fang Dazhi successfully became the controlling shareholder of Northeast Pharmaceutical through a series of increased holding and holding cards. On the question of whether Fang Dajie will seek a controlling stake in Linggang shares through the secondary market, the market participants believe that there is a big difference between Linggang shares and Northeast Pharmacy's ownership structure. Linggang Group, Rongcheng Group and Hongyun Capital have more than 63% of the total share capital, which is certainly unrealistic through the way of increasing their holdings in the secondary market.

According to publicly disclosed information, in the previous increase in holdings of Northeast Pharmaceutical in 2018, Fang Dajie made it clear in the announcement of changes in relevant rights and interests that it did not rule out the possibility of continuing to increase its holdings in the next 12 months. However, this year, Linggang shares were raised twice this year, and in the announcement of changes in relevant rights and interests, Jiujiang Pinggang said that the purpose of the changes in rights and interests is to be optimistic about the future development of the industry in which Linggang shares are engaged in, and to recognize the long-term investment value of Linggang shares. The disclosure obligor has no plans to continue to increase its shareholding in listed companies in the next 12 months.

"the exchange requires a statement that cannot be misleading in the announcement, which is a customary statement in the announcement of equity changes." A professional who has disclosed his work experience for many years told reporters, "the fact that there is no future plan to increase our holdings does not mean that we will not be able to buy them in the future. After all, this is not a promise." In the future, as long as the increase in holdings, as long as in accordance with the provisions of the obligation to disclose information on the line. "

In this regard, some market participants believe that it is difficult to judge whether Fang Dajie will eventually seek a controlling stake in Linggang shares. Although the realization of absolute holding is a common style of Fang Da, but the reality of Linggang shares is that unless there are other arrangements with other important shares, otherwise directly through the secondary market to buy, it is certainly difficult to achieve absolute control. At present, there is still a big gap between Fang Dazhi and Linggang Group.

Lingshan Iron and Steel Co., Ltd.'s reform of equity diversification and acceleration of Fangda held up the license twice in half a year.

Translation 08:26:26AM Jun 12, 2019 Source:Securities Daily
The content below was translated by Tencent automatically for reference.

SMM network news: Fang Dajie once again to Liaoning state-owned enterprises. On the evening of June 10, Linggang announced that during the period from March 8, 2019 to June 10, 2019, Jiujiang Pinggang, owned by Fang Dajie, increased its stake in the company by way of centralized bidding. Fangwei increased its stake by 120000 shares, and the two increased their holdings by 138.5541 million shares, accounting for 5.00 per cent of the total share capital of the company. This is also the second time that Fang Da has raised its license since it was transferred by agreement to transfer 173 million shares of Linggang shares in February this year. So far, Jiujiang Pinggang and its unanimous actor Fang Wei have a total of 319 million shares in Linggang, accounting for 11.50 per cent of the total share capital of the company.

The reporter learned that Linggang Group, as the controlling shareholder of Linggang shares, is also a focus of the reform of state-owned enterprises in recent years. In August last year, the State-owned assets Supervision and Administration Commission of the State Council released a list of "two hundred actions" for the reform of state-owned enterprises, among which Linggang Group was among them.

Linggang Group, founded in 1966, is the largest municipal state-owned enterprise in Chaoyang City, Liaoning Province, with a steel production capacity of 6 million tons. Linggang shares, which were listed on the Shanghai Stock Exchange in 2000, are the most important operating body of Linggang Group at present. At the end of February 2019, the ownership structure of Linggang changed greatly. Fang Dajie and Rongcheng Group accepted the shares originally held by Guangfa Fund and Huafu Fund by way of agreement transfer, both of which became important shareholders of Linggang shares.

In just a few months, Fang Dazhi's increase in his stake in Linggang is also reminiscent of a series of operations on Northeast China Pharmaceutical last year. In 2018, after becoming an important shareholder of Northeast Pharmaceutical through the issuance of additional shares, Fang Dazhi successfully became the controlling shareholder of Northeast Pharmaceutical through a series of increased holding and holding cards. On the question of whether Fang Dajie will seek a controlling stake in Linggang shares through the secondary market, the market participants believe that there is a big difference between Linggang shares and Northeast Pharmacy's ownership structure. Linggang Group, Rongcheng Group and Hongyun Capital have more than 63% of the total share capital, which is certainly unrealistic through the way of increasing their holdings in the secondary market.

According to publicly disclosed information, in the previous increase in holdings of Northeast Pharmaceutical in 2018, Fang Dajie made it clear in the announcement of changes in relevant rights and interests that it did not rule out the possibility of continuing to increase its holdings in the next 12 months. However, this year, Linggang shares were raised twice this year, and in the announcement of changes in relevant rights and interests, Jiujiang Pinggang said that the purpose of the changes in rights and interests is to be optimistic about the future development of the industry in which Linggang shares are engaged in, and to recognize the long-term investment value of Linggang shares. The disclosure obligor has no plans to continue to increase its shareholding in listed companies in the next 12 months.

"the exchange requires a statement that cannot be misleading in the announcement, which is a customary statement in the announcement of equity changes." A professional who has disclosed his work experience for many years told reporters, "the fact that there is no future plan to increase our holdings does not mean that we will not be able to buy them in the future. After all, this is not a promise." In the future, as long as the increase in holdings, as long as in accordance with the provisions of the obligation to disclose information on the line. "

In this regard, some market participants believe that it is difficult to judge whether Fang Dajie will eventually seek a controlling stake in Linggang shares. Although the realization of absolute holding is a common style of Fang Da, but the reality of Linggang shares is that unless there are other arrangements with other important shares, otherwise directly through the secondary market to buy, it is certainly difficult to achieve absolute control. At present, there is still a big gap between Fang Dazhi and Linggang Group.